NEURAXIS, INC. Increase (Decrease) in Accrued Liabilities
NEURAXIS, INC. (NRXS) reported Increase (Decrease) in Accrued Liabilities of $19.86 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-11
- NEURAXIS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$48.35K, a 119.26% decline year-over-year.
- NEURAXIS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $68.21K, a 56.49% decline year-over-year.
- NEURAXIS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $536.75K, a 196.53% increase year-over-year.
- NEURAXIS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $138.17K.
- NEURAXIS, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $1.08M, a 14.01% increase from fiscal 2024.
- NEURAXIS, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $949.69K.
- NEURAXIS, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$294.15K, a 207.98% decline from fiscal 2022.
- NEURAXIS, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $272.43K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$48.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $19.86K 10-Q · filed 2026-08-11 | $556.61K derived: sum of 3 quarters · filed 2026-08-11 | $694.78K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $68.21K 10-Q · filed 2026-05-12 | $604.96K derived: sum of 2 quarters · filed 2026-05-12 | $743.13K derived: sum of 3 quarters · filed 2026-05-12 | $994.16K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $536.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $674.91K derived: sum of 2 quarters · filed 2026-03-19 | $925.94K derived: sum of 3 quarters · filed 2026-08-11 | $1.08M 10-K · filed 2026-03-19 |
| 2025-09-30 | $138.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $389.20K derived: sum of 2 quarters · filed 2026-08-11 | $545.98K 10-Q · filed 2025-11-10 | $726.99K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $251.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $407.81K 10-Q · filed 2026-08-11 | $588.82K derived: sum of 3 quarters · filed 2026-08-11 | $350.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $156.78K 10-Q · filed 2026-05-12 | $337.79K derived: sum of 2 quarters · filed 2026-05-12 | $98.97K derived: sum of 3 quarters · filed 2026-05-12 | $691.08K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $181.01K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$57.81K derived: sum of 2 quarters · filed 2026-03-19 | $534.30K derived: sum of 3 quarters · filed 2026-03-19 | $949.69K 10-K · filed 2026-03-19 |
| 2024-09-30 | -$238.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $353.29K derived: sum of 2 quarters · filed 2025-11-10 | $768.69K 10-Q · filed 2025-11-10 | $889.71K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $592.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.01M 10-Q · filed 2025-08-12 | $1.13M derived: sum of 3 quarters · filed 2025-08-12 | $373.04K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $415.39K 10-Q · filed 2025-05-12 | $536.42K derived: sum of 2 quarters · filed 2025-05-12 | -$219.08K derived: sum of 3 quarters · filed 2025-05-12 | -$65.59K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $121.03K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$634.47K derived: sum of 2 quarters · filed 2025-03-20 | -$480.98K derived: sum of 3 quarters · filed 2025-03-20 | -$294.15K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$755.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$602.01K derived: sum of 2 quarters · filed 2024-11-12 | -$415.18K 10-Q · filed 2024-11-12 | -$398.94K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $153.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $340.32K 10-Q · filed 2024-08-09 | $356.56K derived: sum of 3 quarters · filed 2024-08-09 | $346.26K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $186.83K 10-Q · filed 2024-05-20 | $203.07K derived: sum of 2 quarters · filed 2024-05-20 | $192.77K derived: sum of 3 quarters · filed 2024-05-20 | |
| 2022-12-31 | $16.24K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $5.94K derived: sum of 2 quarters · filed 2024-04-16 | $272.43K 10-K · filed 2024-04-16 | |
| 2022-09-30 | -$10.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $256.18K 10-Q · filed 2023-11-20 | ||
| 2022-06-30 | $266.49K 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |